Currently, there are 381.50M common shares owned by the public and among those 363.53M shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The top 3 mutual fund holders in Agenus Inc are iShares Russell 2000 ETF, Vanguard Total Stock Market ETF, and Vanguard Extended Market Index Fu. iShares Russell 2000 ETF owns 10.31 million shares of the company’s stock, all valued at over $8.54 million. The company sold 27288.0 shares recently to bring their total holdings to about 2.70% of the shares outstanding. Vanguard Extended Market Index Fu bought 0.24 million shares to bring its total holdings to over 5.23 million shares at a value of $4.33 million. Vanguard Extended Market Index Fu now owns shares totaling to 1.37% of the shares outstanding.
The company’s stock has a 5-day price change of 14.64% and -14.82% over the past three months. AGEN shares are trading -19.97% year to date (YTD), with the 12-month market performance down to -72.66% lower. It has a 12-month low price of $0.53 and touched a high of $2.66 over the same period. AGEN has an average intraday trading volume of 10.50 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.47%, -8.26%, and -45.88% respectively.
Institutional ownership of Agenus Inc (NASDAQ: AGEN) shares accounts for 51.38% of the company’s 381.50M shares outstanding. Mutual fund holders own –, while other institutional holders and individual stakeholders account for — and — respectively.
It has a market capitalization of $252.78M and a beta (3y monthly) value of 1.25. The earnings-per-share (ttm) stands at -$0.82. Price movements for the stock have been influenced by the stock’s volatility, which stands at 10.81% over the week and 9.62% over the month.
Analysts forecast that Agenus Inc (AGEN) will achieve an EPS of $Compugen Ltd. for the current quarter, $2.21 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Gen Digital Inc. while analysts give the company a high EPS estimate of $FibroGen, Inc. Comparatively, EPS for the current quarter was $Repligen Corporation a year ago. Earnings per share for the fiscal year are expected to increase by 16.93%, and 38.48% over the next financial year.
Looking at the support for the AGEN, a number of firms have released research notes about the stock. Robert W. Baird stated their Outperform rating for the stock in a research note on June 06, 2023, with the firm’s price target at $8.
